Pujara Chetan Pratap 4
4 · SpyGlass Pharma, Inc. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
SpyGlass Pharma (SGP) Chief R&D Officer Chetan Pujara Receives Award
What Happened
Pujara Chetan Pratap (Chief R&D Officer) received a derivative equity award covering 105,000 shares on Feb 5, 2026. The reported acquisition price is $0.00 (the filing treats this as an award/grant of a derivative). This is a compensation grant (not a market purchase or sale) and does not represent an immediate cash investment or disposition.
Key Details
- Transaction date: February 5, 2026 (Form 4 filed February 9, 2026). Filing appears timely (filed within two business days).
- Transaction type/code: Award/Grant (derivative). Reported acquisition: 105,000 shares at $0.00.
- Shares owned after transaction: Not disclosed in the supplied filing details.
- Footnote (vesting): Award is subject to continued service. 25% vests on the 1-year anniversary of the Vesting Commencement Date (Feb 5, 2026), then 1/48th of the total shares vest each month thereafter (so full vesting over four years, subject to service).
- No indication of immediate exercise or sale; this is an equity compensation grant.
Context
This is a standard executive equity award intended as compensation and retention; it does not indicate an outright purchase or sale by the insider. Because the award vests over time and is contingent on continued service, any future market impact would depend on whether and when options are exercised or shares are sold.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-02-05+105,000→ 105,000 totalExercise: $16.00Exp: 2036-02-05→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 5, 2026.